EUVIMEDEUVIMED entdecken
Crossref

The C242T CYBA Polymorphism as a Major Determinant of NADPH Oxidase Activity in Patients with Cardiovascular Disease

P Mehranpour, S S Wang, R R Blanco, W Li, Q Song, B Lassègue, S I Dikalov, H Austin, A M Zafari

Cardiovascular & Hematological Agents in Medicinal Chemistry · 01.07.2009 · 7 (3) · 251-259

DOI: 10.2174/187152509789105417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular & Hematological Agents in Medicinal Chemistry, erschienen am 01.07.2009. Verfasst von P Mehranpour und 8 weiteren Autor:innen. Beteiligte Einrichtung: Emory University School of Medicine, Division of Cardiology, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single nucleotide polymorphisms (SNP) in the CYBA gene encoding p22(phox) have been associated with respiratory burst and cardiovascular phenotypes. We previously reported a reduced phagocytic respiratory burst activity in healthy adults with the C242T SNP, but found no correlation between CYBA SNPs and coronary artery disease (CAD) phenotype. Using lymphoblastoid cells, we hypothesized that CYBA SNPs affect enzyme activity in patients with cardiovascular disease (CVD), but would not be associated with angiographic severity of CAD due to confounding by risk factors. We established lymphoblastoid cell lines from patients with CVD and genotyped the study cohort for CYBA SNPs and phenotyped each subject's coronary angiogram for CAD severity. As quantified by electron spin resonance, superoxide production in picomoles per 10(6) resting lymphoblastoid cells per minute for the CC, CT, and TT genotypes of the C242T SNP were 16.2+/-1.4, n=70, 11.9+/-0.7, n=87, and 11.9+/-1.5, n=28, respectively (P=0.002). The -930(A/G) and A640G SNPs did not affect superoxide production (P > 0.2). Expression of p22(phox) was not affected as determined by real-time RT-PCR and Western blot analysis. The C242T CYBA SNP is associated with altered NADPH oxidase activity in lymphoblastoid cells of patients with CVD. By reducing the influence of confounding environmental factors, lymphoblastoid cell lines could serve as a tool to assess direct genotype/phenotype interactions of candidate genes known to affect atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymorphism, Single NucleotideAdultAgedCardiovascular DiseasesCell LineCohort StudiesFemaleGene ExpressionHaplotypesHumansMaleMiddle AgedNADPH OxidasesSuperoxides

Substanzen

SuperoxidesNADPH OxidasesCYBA protein, human

Autor:innen und Institutionen

  • Emory University School of Medicine, Division of Cardiology, Atlanta, GA 30322, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Mehranpour, P., Wang, S. S., Blanco, R. R., Li, W., Song, Q., Lassègue, B., Dikalov, S. I., Austin, H., & Zafari, A. M. (2009). The C242T CYBA Polymorphism as a Major Determinant of NADPH Oxidase Activity in Patients with Cardiovascular Disease. Cardiovascular & Hematological Agents in Medicinal Chemistry, 7(3), 251-259. https://doi.org/10.2174/187152509789105417

Vancouver

Mehranpour P, Wang SS, Blanco RR, Li W, Song Q, Lassègue B, et al. The C242T CYBA Polymorphism as a Major Determinant of NADPH Oxidase Activity in Patients with Cardiovascular Disease. Cardiovascular & Hematological Agents in Medicinal Chemistry. 2009;7(3):251-259. doi:10.2174/187152509789105417

BibTeX
@article{Mehranpour2009,
  author = {Mehranpour, P and Wang, S S and Blanco, R R and Li, W and Song, Q and Lassègue, B and Dikalov, S I and Austin, H and Zafari, A M},
  title = {The C242T CYBA Polymorphism as a Major Determinant of NADPH Oxidase Activity in Patients with Cardiovascular Disease},
  journal = {Cardiovascular & Hematological Agents in Medicinal Chemistry},
  year = {2009},
  volume = {7},
  number = {3},
  pages = {251--259},
  doi = {10.2174/187152509789105417}
}
Kostenlos starten →